ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Responsible AI In Clinical Trials Starts With How It Is Designed

  Explore how trials can responsibly use AI to move faster while keeping human judgment, data protections, and auditability intact.

• Veeva Vault EDC Features Brief

  Delve into the details of how Veeva Vault EDC, a cutting-edge cloud-based EDC solution, enables users to design and execute their studies 50% faster with 50% less effort.

• Where PRO Strategy Goes Wrong

  PRO and COA strategy is now central to trial success. Organizations that capture meaningful patient experience data will gain stronger evidence and a regulatory advantage.

• How To Improve Patient Outcomes Using eSource Software In Clinical Trials

  As the demand for patient-centric clinical trials grows, eSource platforms will play an increasingly vital role in facilitating efficient, compliant, and innovative research methodologies.

• Feasibility Insights In HR+/HER2 - Metastatic Breast Cancer

  This case study showcases how advanced analytics were used to streamline feasibility planning for a Phase II clinical trial targeting HR+/HER2- metastatic breast cancer as a second-line treatment.

• Why "Good Enough" Data Is Good Enough For Agentic AI

  Overcome 'data paralysis' and learn why you don’t need perfect data to start leveraging AI and its benefits, and why starting today is much better than waiting for 'perfect.'

• Why Are Sponsor Organizations Using More Than 1 CTMS Solution?

  Explore evolutions in the eClinical market, CTMS use in the outsourcing community, and the difficulty in keeping up with requirements that sponsor organizations, CROs, and clinical trial sites experience regarding their CTMS solutions.

• 5 Important Questions To Ask Your Wearable Technology Partner

  Discuss these questions with any wearable technology partner to establish a solid foundation for a successful collaboration that maximizes the potential of wearable DHTs in your clinical research endeavors.

• Optimizing Wearable Adherence In A Phase 3 Oncology Trial

  Long-term wearable monitoring only works if patients keep wearing the device, and in oncology trials, that’s easier said than done.

• 8 Key Applications Of Real-World Data In Multiple Myeloma Therapy Development

  Explore how therapeutic area (TA) datasets can be leveraged to address the challenges multiple myeloma (MM) presents in the field of hematologic malignancies.